Vitamin D in health and disease: A literature review

British Journal of Biomedical Science

Volumn 70, Issue 4, 2013, Pages 161-172

  Basit, S ^a  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes mellitus; Genetics; Neoplasms; Polymorphisms; Vitamin D

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; HORMONE PRECURSOR; PHOSPHATE; VITAMIN D; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, HUMAN; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

APOPTOSIS; ASTHMA; AUTOIMMUNE DISEASE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CORRELATION ANALYSIS; DIABETES MELLITUS; FALLING; FRACTURE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HYDROXYLATION; IMMUNE SYSTEM; INFECTION; INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MINERAL METABOLISM; MULTIPLE SCLEROSIS; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RICKETS; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; GENETICS; GENOMICS; KIDNEY; LIVER; METABOLISM; NEOPLASM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; APOPTOSIS; ASTHMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTANETRIOL 26-MONOOXYGENASE; DIABETES MELLITUS; GENOMICS; HUMANS; INFERTILITY; KIDNEY; LIVER; NEOPLASMS; OSTEOMALACIA; RECEPTORS, CALCITRIOL; RICKETS; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84893169300     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2013.11669951     Document Type: Review

References (170)

1. Pedersen JI. Vitamin D requirement and setting recommendation levels - current Nordic view. Nutr Rev 2008; 66: S165-9.
2. Mosekilde L. Vitamin D requirement and setting recommendation levels: long-term perspectives. Nutr Rev 2008; 66: S170-7.
3. Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R. Vitamin D and breast cancer: emerging concepts. Cancer Lett 2012; 12: 639-8.
4. Welsh J. Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal models. Scand J Clin Lab Invest Suppl 2012; 243: 103-11.
5. Cooke NE, Haddad JG. Vitamin D binding protein (Gcglobulin). Endocr Rev 1989; 10: 294-307
6. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74: 1966-71. (Pubitemid 15197337)
7. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985; 61: 969-75. (Pubitemid 16218499)
8. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91: 2552-5. (Pubitemid 23182508)
9. Haddad JG. Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol 1995; 53: 579-82.
10. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. Deorphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem 2003; 278: 38084-93. (Pubitemid 37175340)
11. Ohyama Y, Yamasaki T. Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci 2004; 9: 3007-18.
12. Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW. Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 2008; 380: 95-106.
13. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101: 7711-5. (Pubitemid 38658094)
14. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997; 12: 1552-9. (Pubitemid 27422355)
15. Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin d3-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888-94. (Pubitemid 32207511)
16. Flanagan JN, Wang L, Tangpricha V, Reichrath J, Chen TC, Holick MF. Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant. Recent Results Cancer Res 2003; 164: 157-67.
17. Wang L, Whitlatch LW, Flanagan JN, Holick MF, Chen TC. Vitamin D autocrine system and prostate cancer. Recent Results Cancer Res 2003; 164: 223-7.
18. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and production of 1alpha,25- dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102: 3314-6 (Pubitemid 37314772)
19. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80: 1689S-96S.
20. Kogawa M, Findlay DM, Anderson PH et al. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology 2010; 151: 4613-25
21. Panda DK, Miao D, Tremblay ML et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001; 98: 7498-503. (Pubitemid 32567977)
22. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001; 142: 3135-41. (Pubitemid 32575552)
23. Kawashima H, Torikai S, Kurokawa K. Localization of 25-hydroxyvitamin D3 1alpha-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci USA 1981; 78: 1199-203. (Pubitemid 11102188)
24. Zierold C, Darwish HM, DeLuca HF. Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. Proc Natl Acad Sci USA 1994; 91: 900-2.
25. Zehnder D, Bland R, Walker EA et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 1999; 10: 2465-73.
26. Makin G, Lohnes D, Byford V, Ray R, Jones G. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 1989; 262: 173-80. (Pubitemid 19220946)
27. Reddy GS, Tserng KY. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 1989; 28: 1763-9. (Pubitemid 19072051)
28. St-Arnaud R. Novel findings about 24,25-dihydroxyvitamin D: an active metabolite? Curr Opin Nephrol Hypertens 1999; 8: 435-41. (Pubitemid 30004167)
29. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
30. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci USA 1997; 94: 7879-84. (Pubitemid 27343743)
31. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-76.
32. Haussler MR, Whitfield GK, Haussler CA et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325-49. (Pubitemid 28146215)
33. Norman AW. Mini review: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006; 147: 5542-8. (Pubitemid 44833469)
34. Freedman LP, Arce V, Perez Fernandez R. DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 1994; 8: 265-73. (Pubitemid 24108354)
35. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-231. (Pubitemid 28491953)
36. Smolders J, Peelen E, Thewissen M et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009; 8: 621-6.
37. Dowd DR, MacDonald PN. The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin. J Steroid Biochem Mol Biol 2010; 121: 317-21.
38. Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 2010; 24: 128-47.
39. Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, May BK. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 2001; 66: 381-9. (Pubitemid 32143677)
40. Carlberg C, Polly P. Gene regulation by vitamin D 3. Crit Rev Eukaryot Gene Expr 1998; 8: 19-42.
41. Shaffer PL, Gewirth DT. Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J 2002; 21: 2242-52. (Pubitemid 34516783)
42. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000; 5: 173-9. (Pubitemid 30105446)
43. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000; 14: 121-41. (Pubitemid 30070977)
44. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, C arlberg C. VDR-Alien: a novel, DNA-selective vitamin D 3 receptor-corepressor partnership. FASEB J 2000; 14: 1455-63. (Pubitemid 30439755)
45. Leo C, Chen JD. The SRC family of nuclear receptor coactivators. Gene 2000; 245: 1-11 (Pubitemid 30125358)
46. Kwok RP, Lundblad JR, Chrivia JC et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994; 370: 223-6 (Pubitemid 24236779)
47. Castillo AI, Jimenez-Lara AM, Tolon RM, Aranda A. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol Endocrinol 1999; 13: 1141-54 (Pubitemid 30644302)
48. Rachez C, Suldan Z, Ward J et al. A novel protein complex that interacts with the vitamin D 3 receptor in a ligand-dependent manner and enhances transactivation in a cell-free system. Genes Dev 1998; 12: 1787-800. (Pubitemid 28304332)
49. Rachez C, Lemon BD, Suldan Z et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999; 398: 824-8.
50. Ross AC, Manson JE, Abrams SA et al. Clarification of DRIs for calcium and vitamin D across age groups. J Am Diet Assoc 2011; 111: 1467.
51. Holick MF, Binkley NC, Bischoff-Ferrari HA et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
52. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004; 80: 752-8. (Pubitemid 41115542)
53. Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-9. (Pubitemid 351664326)
54. Giovannucci E. Epidemiological evidence for vitamin D and colorectal cancer. J Bone Miner Res 2007; 2: V81-5. (Pubitemid 351304655)
55. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, Pieber TR. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 2009; 29: 3699-704.
56. Tylavsky FA, Cheng S, Lyytikäinen A, Viljakainen H, Lamberg-Allardt C. Strategies to improve vitamin D status in northern European children: exploring the merits of vitamin D fortification and supplementation. J Nutr 2006; 136: 1130-4.
57. Burnand B, Sloutskis D, Gianoli F et al. Serum 25-hydroxyvitamin D: distribution and determinants in the Swiss population. Am J Clin Nutr 1992; 56: 537-42.
58. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 69-77.
59. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008; 88: 1519-27.
60. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011; 25: 671-80.
61. van der Wielen RP, Löwik MR, van den Berg H et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207-10.
62. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-90.
63. Mahdy S, Al-Emadi SA, Khanjar IA et al. Vitamin D status in health care professionals in Qatar. Saudi Med J 2010; 31: 74-7.
64. Heaney RP. Vitamin D, nutritional deficiency, and the medical paradigm. J Clin Endocrinol Metab 2003; 88: 5107-8. (Pubitemid 37452702)
65. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97: 13-9. (Pubitemid 41546209)
66. Sadat-Ali M, Al Elq AH, Al-Turki HA, Al-Mulhim FA, Al-Ali AK. Influence of vitamin D levels on bone mineral density and osteoporosis. Ann Saudi Med 2011; 31: 602-8.
67. Bodnar LM, Catov JM, Zmuda JM et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 2010; 140: 999-1006.
68. Lewis S, Lucas RM, Halliday J et al. Vitamin D deficiency and pregnancy: from preconception to birth. Mol Nutr Food Res 2010; 54: 1092-102.
69. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 37: 113-9. (Pubitemid 351228619)
70. Chesney RW. Vitamin D and The Magic Mountain: the antiinfectious role of the vitamin. J Pediatr 2010; 156: 698-703.
71. Zhang HL, Wu J. Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis. Neurosci Bull 2010; 26: 445-54.
72. Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Eur J Clin Invest 2005; 35: 290-304.
73. Semba RD, Houston DK, Bandinelli S et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64: 203-9.
74. Wang L, Manson JE, Song Y et al. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-23.
75. Drechsler C, Pilz S, Obermayer-Pietsch B et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010; 31: 2253-61.
76. Pilz S, Tomaschitz A, Drechsler C et al. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 2011; 12: 88-96.
77. Levin AD, Wadhera V, Leach ST et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci 2011; 56: 830-6.
78. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002; 13: 187-94. (Pubitemid 34408183)
79. Wimalawansa SJ. Vitamin D: Everything You Need to Know. Homagama, Sri Lanka: Karunaratne, 2011.
80. Hisatake J, O'Kelly J, Uskokovic MR et al. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 2001; 97: 2427-33. (Pubitemid 32291490)
81. Morales-Tirado V, Wichlan DG, Leimig TE et al. 1alpha,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin Immunol 2011; 138: 212-21.
82. Jenab M, Bueno-de-Mesquita HB, Ferrari P et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010; 340: b5500.
83. Karlsson S, Olausson J, Lundh D et al. Vitamin D and prostate cancer: the role of membrane initiated signaling pathways in prostate cancer progression. J Steroid Biochem Mol Biol 2010; 121: 413-6.
84. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16: 83-95. (Pubitemid 40691207)
85. Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 2006; 22: 24-9. (Pubitemid 44124279)
86. Gorham ED, Garland CF, Garland FC et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005; 97: 179-94. (Pubitemid 41546228)
87. Grant WB. The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res 2006; 26: 2605-14. (Pubitemid 44155541)
88. Hyppönen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes Obes Metab 2010; 12: 737-43
89. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women's Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-7. (Pubitemid 38084289)
90. Brehm JM, Celedón JC, Soto-Quiros ME et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179: 765-71.
91. Brehm JM, Schuemann B, Fuhlbrigge AL et al.; Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 2010; 126: 52-8.
92. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007; 120: 1031-5. (Pubitemid 350029909)
93. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009; 19: 73-8.
94. Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 2007; 22: 1668-71. (Pubitemid 351235133)
95. Jones G, Horst R, Carter G, Makin HL. Contemporary diagnosis and treatment of vitamin D-related disorders. J Bone Miner Res 2007; 2: V11-15. (Pubitemid 351304641)
96. Wallace AM, Gibson S, de la Hunty A, Lamberg-Allardt C, Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010; 75: 477-88.
97. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011; 12: 19-28.
98. Binkley N, Krueger DC, Morgan S, Wiebe D. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin Chim Acta 2010; 411: 1976-82.
99. Moon HW, Cho JH, Hur M et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 2012; 45: 326-30.
100. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 2012; 58: 531-42.
101. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012; 58: 543-8.
102. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 2004; 50: 2195-7. (Pubitemid 39425873)
103. Carter GD, Berry JL, Gunter E et al. Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 2010; 121: 176-9.
104. Yetley EA, Pfeiffer CM, Schleicher RL et al.; Vitamin D Roundtable on the NHANES Monitoring of Serum 25(OH)D. Assay challenges and options for resolving them. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr 2010; 140: 2030S-2045S.
105. Binkley N, Krueger D, Cowgill CS et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004; 89: 3152-7. (Pubitemid 38951877)
106. Nowak M, Harrison SL, Buettner PG et al. Vitamin D status of adults from tropical Australia determined using two different laboratory assays: implications for public health messages. Photochem Photobiol 2011; 87: 935-43.
107. Barake M, Daher RT, Salti I et al. 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 2012; 97: 835-43.
108. Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol 2004; 89-90: 187-93 (Pubitemid 38844281)
109. Pilz S, Tomaschitz A. Role of vitamin D in arterial hypertension. Expert Rev Cardiovasc Ther 2010; 8: 1599-608
110. Wuerzner G, Burnier M, Waeber B. Should hypertensive patients take vitamin D? Curr Hypertens Rep 2012; 14: 318-23.
111. Swapna N, Vamsi UM, Usha G, Padma T. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J Hum Genet 2011; 17: 201-6.
112. Poon AH, Laprise C, Lemire M et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med 2004; 170: 967-73. (Pubitemid 39425692)
113. Raby BA, Lazarus R, Silverman EK et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med 2004; 170: 1057-65. (Pubitemid 39488617)
114. Vollmert C, Illig T, Altmüller J et al. Single nucleotide polymorphism screening and association analysis - exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma. Clin Exp Allergy 2004; 34: 1841-50. (Pubitemid 40023633)
115. Wjst M. Variants in the vitamin D receptor gene and asthma. BMC Genet 2005; 6: 2.
116. Butler MW, Burt A, Edwards TL et al. Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 2011; 75: 201-10.
117. Gezen-Ak D, Dursun E, Bilgiç B et al. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med 2012; 228: 189-96.
118. Feng M, Li H, Chen SF, Li WF, Zhang FB. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 2012; 43: 318-26.
119. Cooper JD, Smyth DJ, Walker NM et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60: 1624-31.
120. Hussein AG, Mohamed RH, Alghobashy AA. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol 2012; 279: 42-5.
121. Ramos-Lopez E, Brück P, Jansen T, Herwig J, Badenhoop K. CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev 2007; 23: 631-6. (Pubitemid 350200403)
122. Ramos-Lopez E, Kahles H, Weber S et al. Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes Metab 2008; 10: 683-5. (Pubitemid 352044299)
123. Signorello LB, Shi J, Cai Q et al. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS One 2011; 6: e28623.
124. Orton SM, Morris AP, Herrera BM et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008; 88: 441-7.
125. Bailey R, Cooper JD, Zeitels L et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007; 56: 2616-21. (Pubitemid 47523270)
126. Kitanaka S, Takeyama K, Murayama A et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998; 338: 653-61. (Pubitemid 28108435)
127. Wang JT, Lin CJ, Burridge SM et al. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet 1998; 63: 1694-702. (Pubitemid 30415732)
128. Engelman CD, Fingerlin TE, Langefeld CD et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 2008; 93: 3381-8.
129. Berry D, Hyppönen E. Determinants of vitamin D status: focus on genetic variations. Curr Opin Nephrol Hypertens 2011; 20: 331-6.
130. Ahn J, Albanes D, Berndt SI et al.; Prostate, Lung, Colorectal and Ovarian Trial Project Team. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009; 30: 769-76.
131. Pilz S, Dobnig H, Winklhofer-Roob B et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 2008; 17: 1228-33.
132. Thorne J, Campbell MJ. The vitamin D receptor in cancer. Proc Nutr Soc 2008; 67: 115-27. (Pubitemid 351543394)
133. Schwartz Z, Graham EJ, Wang L et al. Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth plate chondrocytes. J Cell Physiol 2005; 203: 54-70 (Pubitemid 40328172)
134. Nair-Shalliker V, Clements M, Fenech M, Armstrong BK. Personal sun exposure and serum 25-hydroxy vitamin D concentrations. Photochem Photobiol 2012; 89: 208-14.
135. Feskanich D, Ma J, Fuchs CS et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13: 1502-8. (Pubitemid 39202318)
136. Liu G, Wilding G, Staab MJ et al. Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer. Clin Cancer Res 2003; 9: 4077-83. (Pubitemid 37204023)
137. Wactawski-Wende J, Kotchen JM, Anderson GL et al.; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-96. (Pubitemid 43247139)
138. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011; 51: 311-36.
139. Freedman DM, Chang SC, Falk RT et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008; 17: 889-94. (Pubitemid 351536420)
140. Agic A, Xu H, Altgassen C et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1a-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reproductive Sciences 2007; 14: 486-97. (Pubitemid 351168795)
141. Parikh G, Varadinova M, Suwandhi P et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res 2010; 42: 754-7.
142. Henry HL, Norman AW. Vitamin D: metabolism and biological actions. Annu Rev Nutr 1984; 4: 493-520.
143. Tanamura A, Nomura S, Kurauchi O, Furui T, Mizutani S, Tomoda Y. Purification and characterization of 1,25(OH)2D3 receptor from human placenta. J Obstet Gynaeco (Tokyo 1995) 1995; 21: 631-9.
144. Merke J, Hugel U, Ritz E. Nuclear testicular 1,25-dihydroxyvitamin D3 receptors in Sertoli cells and seminiferous tubules of adult rodents. Biochem Biophys Res Commun 1985; 127: 303-9. (Pubitemid 15103445)
145. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol 1996; 105: 7-15. (Pubitemid 26040722)
146. Corbett ST, Hill O,Nangia AK. Vitamin D receptor found in human sperm. Urology 2006; 68: 1345-9. (Pubitemid 44880375)
147. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Ando S. Human sperm anatomy: ultrastructural localization of 1a,25-dihydroxyvitamin D receptor and its possible role in the humanmale gamete. J Anat 2008; 213: 555-64.
148. Blomberg-Jensen M, Nielsen JE et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 2010; 25: 1303-11.
149. Kwiecinski GG, Petrie GI, DeLuca HF. Vitamin D is necessary for reproductive functions of the male rat. J Nutr 1989; 119: 741-4. (Pubitemid 19164460)
150. Osmundsen BC, Huang HF, Anderson MB, Christakos S, Walters MR. Multiple sites of action of the vitamin D endocrine system: FSH stimulation of testis 1,25-dihydroxyvitamin D3 receptors. J Steroid Biochem 1989; 34: 339-43. (Pubitemid 20061806)
151. Du H, Daftary GS, Lalwani SI, Taylor HS. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol 2005; 19: 2222-33. (Pubitemid 41252818)
152. Yoshizawa T, Handa Y, Uematsu Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16: 391-6. (Pubitemid 27323308)
153. Kovacs CS, Woodland ML, Fudge NJ, Friel JK. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am J Physiol Endocrinol Metab 2005; 289: E133-44. (Pubitemid 40874944)
154. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000; 141: 1317-24. (Pubitemid 32269098)
155. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012; 166: 765-78.
156. Ozkan S, Jindal S, Greenseid K et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril 2009; 94: 1314-9.
157. Blomberg-Jensen M, Bjerrum PJ, Jessen TE et al. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod 2011; 26: 1307-17.
158. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005; 48: 1247-57. (Pubitemid 41186086)
159. Casteels K, Waer M, Bouillon R et al. 1,25-dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clin Exp Immunol 1998; 112: 181-7. (Pubitemid 28266675)
160. Littorin B, Blom P, Schölin A et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847-52. (Pubitemid 44730286)
161. Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 2009; 154: 132-4.
162. Janner M, Ballinari P, Mullis PE, Flück CE. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med Wkly 2010; 140: w13091.
163. Pittas AG, Dawson-Hughes B, Li T et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-6. (Pubitemid 44115368)
164. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 28: 2926-32. (Pubitemid 43942926)
165. Daga RA, Laway BA, Shah ZA, Mir SA, Kotwal SK, Zargar AH. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Arq Bras Endocrinol Metabol 2012; 56: 423-8.
166. Pani MA, Knapp M, Donner H et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49: 504-7. (Pubitemid 30131799)
167. Chang TJ, Lei HH, Yeh JI et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf) 2000; 52: 575-80.
168. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3: 235-49. (Pubitemid 38967549)
169. Engelman CD, Meyers KJ, Ziegler JT et al. Genome-wide association study of vitamin D concentrations in Hispanic Americans: the IRAS family study. J Steroid Biochem Mol Biol 2010; 122: 186-92.
170. Lasky-Su J, Lange N, Brehm JM et al. Genome-wide association analysis of circulating vitamin D levels in children with asthma. Hum Genet 2012; 131: 1495-505.